Literature DB >> 26084218

Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension.

M Gibas-Dorna1, D Nowak2, J Piatek2, D Pupek-Musialik3, H Krauss2, P Kopczynski4.   

Abstract

We examined an association between ghrelin, including its major isoforms, interleukin-6 (IL-6), body mass index (BMI), and mean arterial pressure (MAP) in male overweight patients with essential hypertension. Twenty hypertensive male patients with newly diagnosed essential hypertension (EH) before starting drug treatment and 22 age-matched healthy controls were enrolled in the study. Fasting total plasma ghrelin (TGhr), acyl ghrelin (AGhr), des-acyl ghrelin (DGhr) and IL-6 were determined and correlations between studied parameters were calculated. We found significantly lower total plasma ghrelin and higher plasma IL-6 in hypertensives when compared with the control. In patients with hypertension the negative correlations were found: between TGhr and BMI, DGhr and BMI, TGhr and MAP, and between DGhr and MAP. IL-6 positively correlated with BMI and MAP in hypertensive subjects. No correlations between all forms of ghrelin and IL-6 were noted. The changes in plasma ghrelin and IL-6 contribute independently to the elevated blood pressure in essential hypertension. Negative correlation of DGhr and MAP may suggest its hemodynamic involvement in regulation of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26084218

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  6 in total

1.  Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans.

Authors:  Cecilia J Zhang; Martin Bidlingmaier; Mekibib Altaye; Laura C Page; David D'Alessio; Matthias H Tschöp; Jenny Tong
Journal:  Eur J Endocrinol       Date:  2016-11-09       Impact factor: 6.664

2.  Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study.

Authors:  Tobias Daniel Trippel; Volker Holzendorf; Martin Halle; Götz Gelbrich; Kathleen Nolte; Andre Duvinage; Silja Schwarz; Tinka Rutscher; Julian Wiora; Rolf Wachter; Christoph Herrmann-Lingen; Hans-Dirk Duengen; Gerd Hasenfuß; Burkert Pieske; Frank Edelmann
Journal:  ESC Heart Fail       Date:  2016-08-31

Review 3.  Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature.

Authors:  Sean P Didion
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

Review 4.  Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Anca Ouatu; Ciprian Rezus; Manuela Ciocoiu; Claudia Florida Costea; Mariana Floria
Journal:  Int J Hypertens       Date:  2019-05-02       Impact factor: 2.420

5.  Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways.

Authors:  Ruize Qu; Xiaomin Chen; Jing Hu; Yufeng Fu; Jiangfan Peng; Yuhua Li; Jingxi Chen; Peng Li; Long Liu; Jiankang Cao; Wenhan Wang; Cheng Qiu; Linlin Guo; Krasimir Vasilev; Jianying Chen; Gengyin Zhou; Weiwei Li; Yunpeng Zhao
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

6.  Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts.

Authors:  Brad T Sherman; Xiaojun Hu; Kanal Singh; Lillian Haine; Adam W Rupert; James D Neaton; Jens D Lundgren; Tomozumi Imamichi; Weizhong Chang; H Clifford Lane
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.